You are here

  • Home
  • Archive
  • Volume 64, Issue Suppl 1
  • PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3 trials

Article metrics

Article menu
Download PDFPDF
Neurogastroenterology: Functional Disorders, Motility and Clinical Physics
PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3 trials

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015100
Jul 20152002
Aug 2015902
Sep 20151400
Oct 2015701
Nov 20151100
Dec 20152300
Jan 2016601
Feb 2016700
Mar 2016601
Apr 2016500
May 2016600
Jun 2016801
Jul 2016200
Aug 2016410
Sep 2016430
Oct 2016700
Nov 2016500
Dec 2016700
Jan 2017210
Feb 2017401
Mar 2017502
Apr 2017500
May 2017701
Jun 2017500
Jul 2017800
Aug 20172000
Sep 2017800
Oct 20171200
Nov 2017600
Dec 20171400
Jan 20181200
Feb 2018400
Mar 20186205
Apr 20182800
May 20183001
Jun 2018400
Jul 20181000
Aug 2018401
Sep 2018800
Oct 2018200
Nov 2018600
Dec 2018800
Jan 20191000
Feb 20191400
Mar 20191800
Apr 20191800
May 20191000
Jun 20192800
Jul 20192800
Aug 20191600
Sep 20191600
Oct 20191400
Nov 2019400
Dec 20191800
Jan 2020600
Feb 2020400
Mar 20201200
Apr 2020600
May 2020400
Jul 2020801
Aug 2020200
Sep 20207200
Oct 2020400
Nov 20201000
Dec 20201200
Jan 2021600
Feb 2021600
Mar 2021400
Jun 2021100
Oct 20211000
Nov 2021200
Dec 2021803
Jan 20221100
Feb 2022401
Apr 2022600
May 20221201
Jun 20221300
Jul 2022600
Aug 20221100
Sep 20221000
Oct 20221400
Nov 20221000
Dec 20221200
Jan 2023200
Feb 2023400
Mar 2023700
Apr 2023600
May 20231100
Jun 2023700
Jul 2023600
Aug 2023200
Sep 2023600
Oct 2023300
Nov 2023700
Dec 20231000
Jan 2024700
Feb 20241000
Mar 2024900
Total1003525